Novo Nordisk expects high demand for its obesity drugs in India, says country head
Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...
A new weight loss drug could beat Ozempic's side effect problem
The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...
Novo’s New Obesity Drug Is Targeting the Most Dramatic Weight Loss Yet
The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...
Viking slips as manufacturing concerns cloud promising oral obesity drug data
Viking Therapeutics shares climbed 9% on Monday after the drug developer's oral obesity treatment helped reduce body weight ...
Medscape6d
Weight Loss Surgery, Obesity Drugs Achieve Similar Results but Have Different Safety Profiles
PHILADELPHIA — Roux-en-Y gastric bypass (RYGB) produces maximal weight loss in patients with obesity compared with other ...
Can new weight loss drugs fight the US obesity epidemic? Here's what to know
Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer new weight loss drugs?
Novo Nordisk's obesity-fighting drugs fatten Denmark's economy
Danish company Novo Nordisk has a market cap larger than the entire country's GDP. As it grows, it's having an impact on ...
As Race To Best 'Miracle' Obesity Drug Heats Up, Ozempic Maker Novo Nordisk Tests New Hybrid Drug That Can Reduce Weight Up To 25%
Novo's development chief, Martin Holst Lange, has shown optimism about the drug's promise, though he refrained from making ...
Obesity Drug Shows Promise in Easing Knee Osteoarthritis Pain
sold as Ozempic for diabetes and as Wegovy for obesity, was better than any current medications in alleviating symptoms. By ...
Big Pharma’s obesity bonanza faces new tests
Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most ...
Bloomberg L.P.3d
Novo’s New Obesity Drug Is Targeting the Most Dramatic Weight Loss Yet
It broke open a market that could reach $130 billion by 2030 and has a cultural reach broader than any new drug since Viagra. Yet to keep its lead in the red-hot field of obesity, Novo must prove ...